Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Oxford Biomedica Plc
(OP:
OXBDF
)
4.600
-0.075 (-1.60%)
Streaming Delayed Price
Updated: 11:37 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,000
Open
4.600
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
4.675
Today's Range
4.600 - 4.600
52wk Range
2.090 - 4.890
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
July 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1
July 01, 2022
CNBC Why Kohl’s Shares Are Plunging Today
Via
Benzinga
Performance
YTD
+90.87%
+90.87%
1 Month
+2.68%
+2.68%
3 Month
+6.73%
+6.73%
6 Month
+111.01%
+111.01%
1 Year
+7.73%
+7.73%
More News
Read More
Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine
July 01, 2022
Via
Benzinga
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
February 01, 2022
Via
Benzinga
Oxford Biomedica, Homology Medicines Enter Deal To Expand Viral Vector Offerings
January 28, 2022
Via
Benzinga
Oxford BioMedica To Manufacture More Doses Of AstraZeneca's COVID-19 Vaccine, Upgrades 2021 Outlook
May 18, 2021
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
May 18, 2021
Via
Benzinga
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.